Publication | Closed Access

Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial

HepatologyMedicineClinical TrialsLiver CancerAdvanced Hepatocellular CarcinomaCancer TreatmentOncologyRadiation OncologyLow-dose CisplatinHepatocellular CarcinomaPhase 3RadiologyHealth Sciences